The presence of the allele 4 of the apolipoprotein E (APOE) gene, a known genetic risk factor for Alzheimer’s disease (AD), affects the progression of neurodegenerative processes in TBI patients (14) and is associated with increased neurologic complications (15). The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.